ArticleJournal of geriatric cardiology : JGC2022
Validating the accuracy of a multifunctional smartwatch sphygmomanometer to monitor blood pressure.
Article in Journal of geriatric cardiology : JGC, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06627920 (Validation of a Smartwatch for Blood Pressure Measurement), which is not on this map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Validation of a Smartwatch for Blood Pressure Measurement
Who cites it
12 citing papers in PubMed, 10 citations in OpenAlex.
- The Representation of Different Populations in Studies Assessing the Validity of Consumer Wearable Photoplethysmography-Based Measurements: Scoping Review.JMIR mHealth and uHealth · 2026Article
- Comparison of blood pressure measurements between the Huawei Watch D smartwatch application and the validated Omron M3 Intellisense device: Observational study.Experimental physiology · 2026Observational
- The quest for accurate wearable blood pressure monitors.Hypertension research : official journal of the Japanese Society of Hypertension · 2026Review
- EEG response and productivity outcome under changing indoor environment.Frontiers in public health · 2026Article
- Wearable, cuffless, and portable devices for blood pressure monitoring (2015-2025): a scoping review of technologies, calibration, clinical validation, and regulatory frameworks.Frontiers in digital health · 2026Article
- Digital hypertension - what we need for the high-quality management of hypertension in the new era.Hypertension research : official journal of the Japanese Society of Hypertension · 2025Review
- Accessibility and usage patterns of wearable devices among Chinese adults: the Huawei Blood Pressure Health Study.European heart journal. Digital health · 2025Article
- Accuracy and Reduced Sleep Disruption of a Wearable Smartwatch for Nocturnal Blood Pressure Monitoring: A Validation Study.Journal of clinical hypertension (Greenwich, Conn.) · 2025Article
- A Smartwatch or Just a Watch? A Validation Study of the Smartwatch KC08 for Measuring Blood Pressure.Sensors (Basel, Switzerland) · 2025Article
- Diagnostic accuracy of the HUAWEI WATCH D for measuring spinal anesthesia-induced hypotension during elective cesarean section: a diagnostic test.Frontiers in medicine · 2025Article
- A review: Blood pressure monitoring based on PPG and circadian rhythm.APL bioengineering · 2024Review
- Wearable Sensors in Other Medical Domains with Application Potential for Orthopedic Trauma Surgery-A Narrative Review.Journal of clinical medicine · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypertension is the most modifiable factor associated with cardiovascular events and complications. The conventional blood pressure (BP) meter method is simple but is limited in terms of real-time monitoring abnormal BP. Therefore, the development of a multifunction smartwatch (HUAWEI WATCH D) sphygmomanometer could significantly improve integrated BP monitoring.
methodsWe enrolled 361 subjects from Chinese PLA General Hospital, Beijing, China to validate the accuracy of the smartwatch versatile sphygmomanometer using ISO 81060-2:2018. Resting and ambulatory BP accuracy of the smartwatch were compared with gold standard clinical sphygmomanometers using ISO 81060-2:2018 guidelines, the accuracy of 24 h systolic blood pressure (SBP) circadian rhythm monitoring, and diurnal high SBP alert for this smartwatch were assessed using a confusion matrix approach. Additionally, we analyzed online users of different ages for compliance.
resultsEighty-five subjects underwent resting BP measurements; the mean resting BP differences between two devices were -0.683 ± 6.203 mmHg (SBP) (
conclusionsWhen compared with the gold standard clinical sphygmomanometer, smartwatch results were consistent and accurate. Online user feedback showed that elderly individuals cared more about BP monitoring accuracy, with better compliance.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.